Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2001

01-10-2001

Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous

Authors: Vincenzo Eusebi, Stefano Mignani, Frederic Koerner, Tetsunari Oyama

Published in: Breast Cancer | Issue 4/2001

Login to get access
Metadata
Title
Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous
Authors
Vincenzo Eusebi
Stefano Mignani
Frederic Koerner
Tetsunari Oyama
Publication date
01-10-2001
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 4/2001
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967525

Other articles of this Issue 4/2001

Breast Cancer 4/2001 Go to the issue

OriginalPaper

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

OriginalPaper

International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland

EditorialNotes

President’s address: Treatment of tamoxifen-refractory breast cancer — approach by animal models

OriginalPaper

Evolution of breast cancer management: Focus on neoadjuvant chemotherapy

OriginalPaper

The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer

OriginalPaper

3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: Clinical results and future perspectives with reference to FDG-PET

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits